These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7884218)

  • 1. Treatment of late Lyme borreliosis.
    Wahlberg P; Granlund H; Nyman D; Panelius J; Seppälä I
    J Infect; 1994 Nov; 29(3):255-61. PubMed ID: 7884218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of treatment responses in late Lyme borreliosis on the basis of antibody decrease during the follow-up period.
    Panelius J; Seppälä I; Granlund H; Nyman D; Wahlberg P
    Eur J Clin Microbiol Infect Dis; 1999 Sep; 18(9):621-9. PubMed ID: 10534183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG seroprevalence of Lyme borreliosis in the population of the Aland Islands in Finland.
    Carlsson SA; Granlund H; Nyman D; Wahlberg P
    Scand J Infect Dis; 1998; 30(5):501-3. PubMed ID: 10066053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The outcome of Lyme borreliosis in children.
    Aberer E; Kehldorfer M; Binder B; Schauperi H
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):941-4. PubMed ID: 10666805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of ceftriaxone treatment on intraocular Lyme borreliosis.
    Suttorp-Schulten MS; Kuiper H; Kijlstra A; van Dam AP; Rothova A
    Am J Ophthalmol; 1993 Nov; 116(5):571-5. PubMed ID: 8238216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lyme borreliosis: underdiagnosed?--overtreated?].
    Peuckert W
    Monatsschr Kinderheilkd; 1990 Apr; 138(4):190-5. PubMed ID: 2192269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of Lyme borreliosis by an enzyme immunoassay detecting immunoglobulin G reactive to purified Borrelia burgdorferi cell components.
    Bergström S; Sjöstedt A; Dotevall L; Kaijser B; Ekstrand-Hammarström B; Wallberg C; Skogman G; Barbour AG
    Eur J Clin Microbiol Infect Dis; 1991 May; 10(5):422-7. PubMed ID: 1874248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expanding clinical spectrum of ocular lyme borreliosis.
    Mikkilä HO; Seppälä IJ; Viljanen MK; Peltomaa MP; Karma A
    Ophthalmology; 2000 Mar; 107(3):581-7. PubMed ID: 10711899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Suspected Lyme borreliosis: how to diagnose, whom to treat?].
    Bernasconi E; Nadal D; Vogt M
    Ther Umsch; 1992 Apr; 49(4):257-62. PubMed ID: 1615461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lyme borreliosis in childhood].
    Millner M
    Padiatr Padol; 1992; 27(6):A81-93. PubMed ID: 1484707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of results of serological diagnosis of Lyme borreliosis by indirect immunofluorescence and immunoenzyme analysis].
    Kufko IT; Mel'nikov VG; Andreeva EA; Sokolova ZI; Lesniak OM; Beĭkin IaB
    Klin Lab Diagn; 1999 Mar; (3):34-7. PubMed ID: 10234931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serodiagnosis of Lyme borreliosis using detection of different immunoglobulin (sub)classes by enzyme-linked immunosorbent assay and Western blotting.
    Goossens HA; van den Bogaard AE; Nohlmans MK
    Clin Lab; 2001; 47(1-2):41-9. PubMed ID: 11214222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxycycline versus ceftriaxone for the treatment of patients with chronic Lyme borreliosis.
    Ogrinc K; Logar M; Lotric-Furlan S; Cerar D; Ruzić-Sabljić E; Strle F
    Wien Klin Wochenschr; 2006 Nov; 118(21-22):696-701. PubMed ID: 17160610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term serological follow-up of patients treated for chronic cutaneous borreliosis or culture-positive erythema migrans.
    Lomholt H; Lebech AM; Hansen K; Brandrup F; Halkier-Sørensen L
    Acta Derm Venereol; 2000; 80(5):362-6. PubMed ID: 11200835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease.
    Kalish RA; McHugh G; Granquist J; Shea B; Ruthazer R; Steere AC
    Clin Infect Dis; 2001 Sep; 33(6):780-5. PubMed ID: 11512082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporomandibular joint involvement caused by Borrelia Burgdorferi.
    Lesnicar G; Zerdoner D
    J Craniomaxillofac Surg; 2007 Dec; 35(8):397-400. PubMed ID: 17942315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic possibilities and limitations in Lyme borreliosis].
    Satz N; Knoblauch M
    Schweiz Med Wochenschr; 1989 Dec; 119(52):1883-93. PubMed ID: 2692151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiologic, ecologic and clinical characteristics of Lyme borrelliosis in northwest Croatia.
    Golubić D; Rijpkema S; Tkalec-Makovec N; Ruzić E
    Acta Med Croatica; 1998; 52(1):7-13. PubMed ID: 9599811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre.
    Zwerink M; Zomer TP; van Kooten B; Blaauw G; van Bemmel T; van Hees BC; Vermeeren YM; Landman GW
    Ticks Tick Borne Dis; 2018 Mar; 9(3):594-597. PubMed ID: 29422448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis.
    Preac-Mursic V; Weber K; Pfister HW; Wilske B; Gross B; Baumann A; Prokop J
    Infection; 1989; 17(6):355-9. PubMed ID: 2613324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.